Table 1.
Clinicopathological Characteristics of HCC Patients, n (%)
| Characteristic | Total (n = 303) | Characteristic | Total (n = 303) |
|---|---|---|---|
| Age, yr | AFP(ng/dL) | ||
| ≥60 | 97 (32.01%) | >400 | 40 (13.02%) |
| < 60 | 206 (67.99%) | ≤400 | 263 (86.98%) |
| Gender | PLT 109/L | ||
| Male | 254 (83.82%) | >100 | 232 (76.57%) |
| Female | 49 (16.17%) | ≤100 | 71 (23.43%) |
| HBsAg | Liver cirrhosis | ||
| Positive | 260 (85.81%) | Yes | 232 (76.57%) |
| Negative | 43 (14.19%) | No | 71 (23.43%) |
| AST(U/L) | Child-pugh grade | ||
| >40 | 148 (48.84%) | Grade A | 289 (95.38%) |
| ≤40 | 155 (51.16%) | Grade B | 14 (4.62%) |
| ALT(U/L) | Lymph node metastasis | ||
| >40 | 125 (41.25%) | Yes | 24 (7.92%) |
| ≤40 | 178 (58.74%) | No | 279 (92.08%) |
| GGT(U/L) | PVTT | ||
| >75 | 133 (43.89%) | Yes | 45 (14.85%) |
| ≤75 | 170 (56.11%) | No | 258 (85.15%) |
| ALP(U/L) | Tumor number | ||
| >110 | 147 (48.51%) | Single | 114 (37.62%) |
| ≤110 | 156 (51.49%) | Multiple | 189 (62.38%) |
| ALB(g/L) | Tumor size(cm) | ||
| >40 | 172 (56.77%) | > 5 | 143 (47.19%) |
| ≤40 | 131 (43.23%) | ≤ 5 | 160 (52.81%) |
| TB (µmol/L) | TNM | ||
| > 17.1 | 154 (50.82%) | I+II | 224 (73.93%) |
| ≤ 17.1 | 149 (49.17%) | III+IV | 79 (26.07%) |